Athanor Capital, LP Gilead Sciences, Inc. Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $320,880 - $366,124	-5,348 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $901,924 - $1.03 Million	-15,921 Reduced 74.86%	5,348 $312,000
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $960,562 - $1.21 Million	15,468 Added 266.64%	21,269 $1.34 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $419,644 - $487,284	5,801 New	5,801 $446,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.